Marsh (MRSH) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Apr, 2026Executive summary
Q1 2026 revenue grew 8% to $7.6B, with underlying growth of 4%, and net income attributable to the company was $1.1B.
Adjusted operating income rose 8% to $2.4B, while GAAP operating income declined 12% due to a $425M Greensill litigation charge.
Adjusted EPS increased 8% to $3.29; GAAP EPS was $2.36, down 15% year-over-year.
Leadership changes and continued investment in talent, technology, and AI-driven solutions to enhance client value and operational efficiency.
The THRIVE program continues to focus on growth, efficiency, and talent investment, with $45M in restructuring costs in Q1.
Financial highlights
Consolidated revenue: $7.6B, up 8% year-over-year; underlying growth 4%.
Adjusted operating income: $2.4B, up 8%; GAAP operating income: $1.8B, down 12%.
Adjusted operating margin: 31.8%; Risk & Insurance Services margin: 38.3%; Consulting margin: 21.6%.
Adjusted EPS: $3.29, up 8%; GAAP EPS: $2.36.
Repurchased $750M of stock in Q1; 4.2M shares repurchased.
Outlook and guidance
Expect underlying revenue growth in 2026 similar to 2025, with continued margin expansion and solid adjusted EPS growth anticipated.
More margin expansion expected in the second half of 2026.
Adjusted effective tax rate projected between 24.5% and 25.5% for 2026.
Thrive program expected to deliver ~$400M in annualized savings over three years, with $500M in costs.
Management highlighted strong execution in a dynamic environment and confidence in continued growth.
Latest events from Marsh
- Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.MRSH
Proxy filing31 Mar 2026 - Strong 2025 results, robust governance, and high say-on-pay support highlight this proxy filing.MRSH
Proxy filing31 Mar 2026 - 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202419 Jan 2026 - Strong 2024 growth, record acquisitions, and margin expansion set up a positive 2025 outlook.MRSH
Q4 20249 Jan 2026 - Q1 2025 revenue up 9%, adjusted EPS up 5%, with strong segment growth and capital returns.MRSH
Q1 202519 Dec 2025 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and incentive plan, all board-backed.MRSH
Proxy Filing1 Dec 2025